ecrin-mdr-crcClinical2010CRCColorectal cancerColonic NeoplasmsCancerCrcColorectal CancerColonic NeoplasmsCancerInterventionalhttps://newmdr.ecrin.org/Study/2103210Greece10Adjuvant chemotherapyOxaliplatinCapecitabineLevoleucovorinLeucovorin5 fluorouracilFluorouracilECRIN MDRNot providedfalseAdjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon CancerThe purpose of this study is to compare whether a 3-month treatment is at least not inferior to a 6-month treatment (FOLFOX-4 6 vs. 12 cycles or XELOX 4 cycles vs. 8 cycles) in terms of RFS in patients with high risk stage II or stage III radically resected colon cancer.2010-10-152103210NCT01308086